The role of leptin in glucose homeostasis

Journal of Diabetes Investigation

Volumn 3, Issue 2, 2012, Pages 115-129

  Denroche, Heather C ^a   Huynh, Frank K ^a   Kieffer, Timothy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adipokine; Diabetes; Glucose metabolism

Indexed keywords

INSULIN; LEPTIN; LEPTIN RECEPTOR;

ADIPOCYTE; CLINICAL EFFECTIVENESS; DIET THERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN SENSITIVITY; KINESIOTHERAPY; LIVER CELL; LOW DRUG DOSE; METABOLIC DISORDER; MOLECULAR DYNAMICS; NONHUMAN; OBESITY; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; WEIGHT REDUCTION;

EID: 84859144035     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2012.00203.x     Document Type: Review

References (207)

1. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950; 41: 317-318.
2. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 1966; 153: 1127-1128.
3. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9: 294-298.
4. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
5. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
6. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
7. Gibson WT, Farooqi IS, Moreau M, et al. Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab 2004; 89: 4821-4826.
8. Strobel A, Issad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18: 213-215.
9. Fischer-Posovszky P, von Schnurbein J, Moepps B, et al. A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab 2010; 95: 2836-2840.
10. Mazen I, El-Gammal M, Abdel-Hamid M, et al. A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Mol Genet Metab 2009; 97: 305-308.
11. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110: 1093-1103.
12. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004; 101: 4531-4536.
13. Paz-Filho GJ, Babikian T, Asarnow R, et al. Leptin replacement improves cognitive development. PLoS ONE 2008; 3: e3098.
14. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-884.
15. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271.
16. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-635.
17. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 491-495.
18. Ghilardi N, Ziegler S, Wiestner A, et al. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93: 6231-6235.
19. Vaisse C, Halaas JL, Horvath CM, et al. Leptin activation of Stat3 in the hypothalamus of wild-typeand ob/ob mice but not db/db mice. Nat Genet 1996; 14: 95-97.
20. Bahrenberg G, Behrmann I, Barthel A, et al. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol Endocrinol 2002; 16: 859-872.
21. Bates SH, Stearns WH, Dundon TA, et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003; 421: 856-859.
22. Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem Genet 1972; 7: 1-13.
23. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973; 9: 287-293.
24. Frederich RC, Hamann A, Anderson S, et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
25. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
26. Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
27. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
28. Genuth SM, Przybylski RJ, Rosenberg DM. Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology 1971; 88: 1230-1238.
29. Genuth SM. Hyperinsulinism in mice with genetically determined obesity. Endocrinology 1969; 84: 386-391.
30. Coleman DL, Hummel KP. Hyperinsulinemia in pre-weaning diabetes (db) mice. Diabetologia 1974; 10(Suppl): 607-610.
31. Grundleger ML, Godbole VY, Thenen SW. Age-dependent development of insulin resistance of soleus muscle in genetically obese (ob/ob) mice. Am J Physiol Endocrinol Metab 1980; 239: E363-E371.
32. Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 1976; 25: 1567-1574.
33. Dubuc PU, Willis PL. Postweaning development of diabetes in ob/ob mice. Metabolism 1979; 28: 633-640.
34. Rohner-Jeanrenaud F, Hochstrasser AC, Jeanrenaud B. Hyperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Am J Physiol Endocrinol Metab 1983; 244: E317-E322.
35. Russell JC, Ahuja SK, Manickavel V, et al. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat. Arteriosclerosis 1987; 7: 620-626.
36. Schwarzer K, Doring H, Schmidt I. Different physiological traits underlying increased body fat of fatty (fa/fa) and heterozygous (+/fa) rats. Am J Physiol Endocrinol Metab 1997; 272(1 Pt 1): E100-E106.
37. Zarjevski N, Doyle P, Jeanrenaud B. Muscle insulin resistance may not be a primary etiological factor in the genetically obese fa/fa rat. Endocrinology 1992; 130: 1564-1570.
38. Levi J, Gray SL, Speck M, et al. Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance. Endocrinology 2011; 152: 3385-3395.
39. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002; 346: 570-578.
40. Shimomura I, Hammer RE, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76.
41. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531-535.
42. Levin N, Nelson C, Gurney A, et al. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA 1996; 93: 1726-1730.
43. Mistry AM, Swick AG, Romsos DR. Leptin acts peripherally to limit meal-induced increases in plasma insulin concentrations in mice: a brief communication. Exp Biol Med (Maywood) 2004; 229: 1033-1037.
44. Seufert J, Kieffer TJ, Habener JF. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 1999; 96: 674-679.
45. Lam NT, Lewis JT, Cheung AT, et al. Leptin increases hepatic insulin sensitivity and protein tyrosine phosphatase 1B expression. Mol Endocrinol 2004; 18: 1333-1345.
46. Oosman SN, Lam AW, Harb G, et al. Treatment of obesity and diabetes in mice by transplant of gut cells engineered to produce leptin. Mol Ther 2008; 16: 1138-1145.
47. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010; 11: 11-22.
48. Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin deficient diabetes in the rat. Diabetes 1999; 48: 1487-1492.
49. Yu X, Park BH, Wang MY, et al. Making insulin deficient type1 diabetic rodents thrive without insulin. Proc Natl Acad Sci USA 2008; 105: 14070-14075.
50. German JP, Thaler JP, Wisse BE, et al. Leptin Activates a Novel CNS Mechanism for Insulin-Independent Normalization of Severe Diabetic Hyperglycemia. Endocrinology 2010; 152: 394-404.
51. Hidaka S, Yoshimatsu H, Kondou S, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J 2002; 16: 509-518.
52. da Silva AA, Tallam LS, Liu J, et al. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Physiol Regul Integr Comp Physiol 2006; 291: R1275-R1282.
53. da Silva AA, do Carmo JM, Freeman JN, et al. A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes 2009; 58: 1749-1756.
54. do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. Am J Physiol Heart Circ Physiol 2008; 295: H1974-H1981.
55. Denroche HC, Levi J, Wideman RD, et al. Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes 2011; 60: 1414-1423.
56. Kojima S, Asakawa A, Amitani H, et al. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin deficient diabetic mice. Peptides 2009; 30: 962-966.
57. Fujikawa T, Chuang JC, Sakata I, et al. Leptin therapy improves insulin deficient type1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA 2010; 107: 17391-17396.
58. Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulin deficient typeI diabetes. Proc Natl Acad Sci USA 2010; 107: 4813-4819.
59. Ueno N, Inui A, Kalra PS, et al. Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides 2006; 27: 2332-2342.
60. Naito M, Fujikura J, Ebihara K, et al. Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin deficient diabetic mice. Diabetes 2011; 60: 2265-2273.
61. Kruger AJ, Yang C, Lipson KL, et al. Leptin treatment confers clinical benefit at multiple stages of virally induced type1 diabetes in BB rats. Autoimmunity 2010; 44: 137-148.
62. Lin CY, Higginbotham DA, Judd RL, et al. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2002; 282: E1084-E1091.
63. Miyanaga F, Ogawa Y, Ebihara K, et al. Leptin as an adjunct of insulin therapy in insulin deficient diabetes. Diabetologia 2003; 46: 1329-1337.
64. Dobbs R, Sakurai H, Sasaki H, et al. Glucagon: role in the hyperglycemia of diabetes mellitus. Science 1975; 187: 544-547.
65. Brand CL, Rolin B, Jorgensen PN, et al. Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia 1994; 37: 985-993.
66. Johnson DG, Goebel CU, Hruby VJ, et al. Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science 1982; 215: 1115-1116.
67. Unson CG, Gurzenda EM, Merrifield RB. Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist. Peptides 1989; 10: 1171-1177.
68. Van Tine BA, Azizeh BY, Trivedi D, et al. Low level cyclic adenosine 3′, 5′-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists. Endocrinology 1996; 137: 3316-3322.
69. Lee Y, Wang MY, Du XQ, et al. Glucagon receptor knockout prevents insulin deficient type1 diabetes in mice. Diabetes 2011; 60: 391-397.
70. Havel PJ, Uriu-Hare JY, Liu T, et al. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol Regul Integr Comp Physiol 1998; 274(5 Pt 2): R1482-R1491.
71. Soliman AT, Omar M, Assem HM, et al. Serum leptin concentrations in children with type1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Metabolism 2002; 51: 292-296.
72. Sindelar DK, Havel PJ, Seeley RJ, et al. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 1999; 48: 1275-1280.
73. German JP, Wisse BE, Thaler JP, et al. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes 2010; 59: 1626-1634.
74. Morton GJ, Schwartz MW. Leptin and the central nervous system control of glucose metabolism. Physiol Rev 2011; 91: 389-411.
75. Marino JS, Xu Y, Hill JW. Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol Metab 2011; 22: 275-285.
76. Gautron L, Elmquist JK. Sixteen years and counting: an update on leptin in energy balance. J Clin Invest 2011; 121: 2087-2093.
77. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
78. Weigle DS, Bukowski TR, Foster DC, et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96: 2065-2070.
79. Kulkarni RN, Wang ZL, Wang RM, et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 1997; 100: 2729-2736.
80. Emilsson V, Liu YL, Cawthorne MA, et al. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997; 46: 313-316.
81. Laubner K, Kieffer TJ, Lam NT, et al. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. Diabetes 2005; 54: 3410-3417.
82. Cases JA, Gabriely I, Ma XH, et al. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001; 50: 348-352.
83. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1996; 224: 522-527.
84. Kieffer TJ, Heller RS, Leech CA, et al. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes 1997; 46: 1087-1093.
85. Seufert J, Kieffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 670-676.
86. Zhao AZ, Bornfeldt KE, Beavo JA. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 1998; 102: 869-873.
87. Poitout V, Rouault C, Guerre-Millo M, et al. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology 1998; 139: 822-826.
88. Tsiotra PC, Tsigos C, Raptis SA. TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int J Obes Relat Metab Disord 2001; 25: 1018-1026.
89. Fehmann HC, Peiser C, Bode HP, et al. Leptin: a potent inhibitor of insulin secretion. Peptides 1997; 18: 1267-1273.
90. Ishida K, Murakami T, Mizuno A, et al. Leptin suppresses basal insulin secretion from rat pancreatic islets. Regul Pept 1997; 70: 179-182.
91. Ookuma M, Ookuma K, York DA. Effects of leptin on insulin secretion from isolated rat pancreatic islets. Diabetes 1998; 47: 219-223.
92. Pallett AL, Morton NM, Cawthorne MA, et al. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochem Biophys Res Commun 1997; 238: 267-270.
93. Roduit R, Thorens B. Inhibition of glucose-induced insulin secretion by long-term preexposure of pancreatic islets to leptin. FEBS Lett 1997; 415: 179-182.
94. Leclercq-Meyer V, Malaisse WJ. Failure of human and mouse leptin to affect insulin, glucagon and somatostatin secretion by the perfused rat pancreas at physiological glucose concentration. Mol Cell Endocrinol 1998; 141: 111-118.
95. Leclercq-Meyer V, Considine RV, Sener A, et al. Do leptin receptors play a functional role in the endocrine pancreas? Biochem Biophys Res Commun 1996; 229: 794-798.
96. Karlsson E, Stridsberg M, Sandler S. Leptin regulation of islet amyloid polypeptide secretion from mouse pancreatic islets. Biochem Pharmacol 1998; 56: 1339-1346.
97. Tanizawa Y, Okuya S, Ishihara H, et al. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic beta cells. Endocrinology 1997; 138: 4513-4516.
98. Shimizu H, Ohtani K, Tsuchiya T, et al. Leptin stimulates insulin secretion and synthesis in HIT-T 15 cells. Peptides 1997; 18: 1263-1266.
99. Lam NT, Cheung AT, Riedel MJ, et al. Leptin reduces glucose transport and cellular ATP levels in INS-1 beta-cells. J Mol Endocrinol 2004; 32: 415-424.
100. Harvey J, McKenna F, Herson PS, et al. Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1. J Physiol 1997; 504(Pt 3): 527-535.
101. Ahren B, Havel PJ. Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells). Am J Physiol Regul Integr Comp Physiol 1999; 277(4 Pt 2): R959-R966.
102. Lee JW, Swick AG, Romsos DR. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway. Exp Biol Med (Maywood) 2003; 228: 175-182.
103. Chen NG, Swick AG, Romsos DR. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. J Clin Invest 1997; 100: 1174-1179.
104. Covey SD, Wideman RD, McDonald C, et al. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab 2006; 4: 291-302.
105. Gray SL, Donald C, Jetha A, et al. Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling. Endocrinology 2010; 151: 4178-4186.
106. Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007; 117: 2860-2868.
107. Song J, Xu Y, Hu X, et al. Brain expression of Cre recombinase driven by pancreas-specific promoters. Genesis 2010; 48: 628-634.
108. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002; 129: 2447-2457.
109. Hinoi E, Gao N, Jung DY, et al. An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Ann N Y Acad Sci 2009; 1173(Suppl 1): E20-E30.
110. Cohen P, Zhao C, Cai X, et al. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 2001; 108: 1113-1121.
111. Amstalden M, Garcia MR, Stanko RL, et al. Central infusion of recombinant ovine leptin normalizes plasma insulin and stimulates a novel hypersecretion of luteinizing hormone after short-term fasting in mature beef cows. Biol Reprod 2002; 66: 1555-1561.
112. Bagnasco M, Dube MG, Katz A, et al. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obes Res 2003; 11: 1463-1470.
113. Park S, Ahn IS, Kim da S. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type2 diabetic rat model. Life Sci 2010; 24: 854-862.
114. Boghossian S, Dube MG, Torto R, et al. Hypothalamic clamp on insulin release by leptin-transgene expression. Peptides 2006; 27: 3245-3254.
115. Muzumdar R, Ma X, Yang X, et al. Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. FASEB J 2003; 17: 1130-1132.
116. Park S, Hong SM, Sung SR, et al. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Endocrinology 2008; 149: 445-454.
117. Mizuno A, Murakami T, Otani S, et al. Leptin affects pancreatic endocrine functions through the sympathetic nervous system. Endocrinology 1998; 139: 3863-3870.
118. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 2000; 278: E1-E14.
119. Dubuc PU, Mobley PW, Mahler RJ, et al. Immunoreactive glucagon levels in obese-hyperglycemic (ob/ob) mice. Diabetes 1977; 26: 841-846.
120. Della-Fera MA, Choi YH, Hartzell DL, et al. Sensitivity of ob/ob mice to leptin-induced adipose tissue apoptosis. Obes Res 2005; 13: 1540-1547.
121. Tuduri E, Marroqui L, Soriano S, et al. Inhibitory effects of leptin on pancreatic alpha-cell function. Diabetes 2009; 58: 1616-1624.
122. Marroqui L, Vieira E, Gonzalez A, et al. Leptin downregulates expression of the gene encoding glucagon in alphaTC1-9 cells and mouse islets. Diabetologia 2011; 54: 843-851.
123. Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem 2001; 276: 49066-49076.
124. Rossetti L, Massillon D, Barzilai N, et al. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 1997; 272: 27758-27763.
125. Liu L, Karkanias GB, Morales JC, et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 1998; 273: 31160-31167.
126. Barzilai N, Wang J, Massilon D, et al. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997; 100: 3105-3110.
127. Burcelin R, Kamohara S, Li J, et al. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 1999; 48: 1264-1269.
128. O'Doherty RM, Anderson PR, Zhao AZ, et al. Sparing effect of leptin on liver glycogen stores in rats during the fed-to-fasted transition. Am J Physiol Endocrinol Metab 1999; 277(3 Pt 1): E544-E550.
129. Kamohara S, Burcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389: 374-377.
130. Briscoe CP, Hanif S, Arch JR, et al. Leptin receptor long-form signalling in a human liver cell line. Cytokine 2001; 14: 225-229.
131. Szanto I, Kahn CR. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA 2000; 97: 2355-2360.
132. Raman P, Donkin SS, Spurlock ME. Regulation of hepatic glucose metabolism by leptin in pig and rat primary hepatocyte cultures. Am J Physiol Regul Integr Comp Physiol 2004; 286: R206-R216.
133. Huynh FK, Levi J, Denroche HC, et al. Disruption of hepatic leptin signaling protects mice from age- and diet-related glucose intolerance. Diabetes 2010; 59: 3032-3040.
134. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
135. Anderwald C, Muller G, Koca G, et al. Short-term leptin-dependent inhibition of hepatic gluconeogenesis is mediated by insulin receptor substrate-2. Mol Endocrinol 2002; 16: 1612-1628.
136. Ceccarini G, Flavell RR, Butelman ER, et al. PET imaging of leptin biodistribution and metabolism in rodents and primates. Cell Metab 2009; 10: 148-159.
137. Lam NT, Covey SD, Lewis JT, et al. Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver. J Mol Endocrinol 2006; 36: 163-174.
138. Aiston S, Agius L. Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes 1999; 48: 15-20.
139. Ceddia RB, Lopes G, Souza HM, et al. Acute effects of leptin on glucose metabolism of in situ rat perfused livers and isolated hepatocytes. Int J Obes Relat Metab Disord 1999; 23: 1207-1212.
140. Zhao AZ, Shinohara MM, Huang D, et al. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 2000; 275: 11348-11354.
141. Brabant G, Muller G, Horn R, et al. Hepatic leptin signaling in obesity. FASEB J 2005; 19: 1048-1050.
142. Nemecz M, Preininger K, Englisch R, et al. Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver. Hepatology 1999; 29: 166-172.
143. van den Hoek AM, Teusink B, Voshol PJ, et al. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J Neuroendocrinol 2008; 20: 120-127.
144. Pocai A, Morgan K, Buettner C, et al. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 2005; 54: 3182-3189.
145. German J, Kim F, Schwartz GJ, et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 2009; 150: 4502-4511.
146. Gutierrez-Juarez R, Obici S, Rossetti L. Melanocortin-independent effects of leptin on hepatic glucose fluxes. J Biol Chem 2004; 279: 49704-49715.
147. Li X, Wu X, Camacho R, et al. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. PLoS ONE 2011; 6: e17058.
148. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339-343.
149. Harris RB. Acute and chronic effects of leptin on glucose utilization in lean mice. Biochem Biophys Res Commun 1998; 245: 502-509.
150. Minokoshi Y, Haque MS, Shimazu T. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 1999; 48: 287-291.
151. Ceddia RB, William WN Jr, et al. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord 1999; 23: 75-82.
152. Wang JL, Chinookoswong N, Scully S, et al. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 1999; 140: 2117-2124.
153. Yaspelkis BB 3rd, Davis JR, Saberi M, et al. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats. Am J Physiol Endocrinol Metab 2001; 280: E130-E142.
154. Guerra B, Santana A, Fuentes T, et al. Leptin receptors in human skeletal muscle. J Appl Physiol 2007; 102: 1786-1792.
155. Ramsay TG, Richards MP. Leptin and leptin receptor expression in skeletal muscle and adipose tissue in response to in vivo porcine somatotropin treatment. J Anim Sci 2005; 83: 2501-2508.
156. Berti L, Kellerer M, Capp E, et al. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect. Diabetologia 1997; 40: 606-609.
157. Bates SH, Gardiner JV, Jones RB, et al. Acute stimulation of glucose uptake by leptin in l6 muscle cells. Horm Metab Res 2002; 34: 111-115.
158. Ceddia RB, William WN Jr, et al. Leptin increases glucose transport and utilization in skeletal muscle in vitro. Gen Pharmacol 1998; 31: 799-801.
159. Sweeney G, Keen J, Somwar R, et al. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Endocrinology 2001; 142: 4806-4812.
160. Liu YL, Emilsson V, Cawthorne MA. Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice. FEBS Lett 1997; 411: 351-355.
161. Muoio DM, Dohm GL, Tapscott EB, et al. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol Endocrinol Metab 1999; 276(5 Pt 1): E913-E921.
162. Muoio DM, Dohm GL, Fiedorek FT Jr, et al. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997; 46: 1360-1363.
163. Zierath JR, Frevert EU, Ryder JW, et al. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 1998; 47: 1-4.
164. Kellerer M, Koch M, Metzinger E, et al. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 1997; 40: 1358-1362.
165. Akasaka Y, Tsunoda M, Ide T, et al. Chronic leptin treatment stimulates lipid oxidation in immortalized and primary mouse skeletal muscle cells. Biochim Biophys Acta 2009; 1791: 103-109.
166. Olsen GS, Hansen BF. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle. Am J Physiol Endocrinol Metab 2002; 283: E965-E970.
167. Shimabukuro M, Koyama K, Chen G, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637-4641.
168. Chen G, Koyama K, Yuan X, et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 1996; 93: 14795-14799.
169. Toda C, Shiuchi T, Lee S, et al. Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes 2009; 58: 2757-2765.
170. Roman EA, Reis D, Romanatto T, et al. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism. Mol Cell Endocrinol 2010; 314: 62-69.
171. Cusin I, Zakrzewska KE, Boss O, et al. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 1998; 47: 1014-1019.
172. Rouru J, Cusin I, Zakrzewska KE, et al. Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue. Endocrinology 1999; 140: 3688-3692.
173. Fei H, Okano HJ, Li C, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997; 94: 7001-7005.
174. Hoggard N, Hunter L, Duncan JS, et al. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA 1997; 94: 11073-11078.
175. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, et al. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997; 100: 2858-2864.
176. Huan JN, Li J, Han Y, et al. Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance. J Biol Chem 2003; 278: 45638-45650.
177. Muller G, Ertl J, Gerl M, et al. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272: 10585-10593.
178. Kraus D, Fasshauer M, Ott V, et al. Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes. J Endocrinol 2002; 175: 185-191.
179. Perez C, Fernandez-Galaz C, Fernandez-Agullo T, et al. Leptin impairs insulin signaling in rat adipocytes. Diabetes 2004; 53: 347-353.
180. Walder K, Filippis A, Clark S, et al. Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol 1997; 155: R5-R7.
181. Wang MY, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem 1999; 274: 17541-17544.
182. Enriori PJ, Sinnayah P, Simonds SE, et al. Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci 2011; 31: 12189-12197.
183. Haque MS, Minokoshi Y, Hamai M, et al. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes 1999; 48: 1706-1712.
184. Ahima RS, Prabakaran D, Flier JS. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest 1998; 101: 1020-1027.
185. Bornstein SR, Uhlmann K, Haidan A, et al. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997; 46: 1235-1238.
186. Heiman ML, Ahima RS, Craft LS, et al. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997; 138: 3859-3863.
187. Pralong FP, Roduit R, Waeber G, et al. Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland. Endocrinology 1998; 139: 4264-4268.
188. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401.
189. Carro E, Senaris R, Considine RV, et al. Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997; 138: 2203-2206.
190. Vuagnat BA, Pierroz DD, Lalaoui M, et al. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat. Neuroendocrinology 1998; 67: 291-300.
191. Tannenbaum GS, Gurd W, Lapointe M. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 1998; 139: 3871-3875.
192. Anini Y, Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003; 52: 252-259.
193. Levi J, Huynh FK, Denroche HC, et al. Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Diabetologia 2011; 55: 752-762.
194. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282: 1568-1575.
195. Mittendorfer B, Horowitz JF, DePaoli AM, et al. Recombinant human leptin treatment does not improve insulin action in obese subjects with type2 diabetes. Diabetes 2011; 60: 1474-1477.
196. Rosenbaum M, Murphy EM, Heymsfield SB, et al. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002; 87: 2391-2394.
197. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 1997; 82: 3647-3654.
198. Rosenbaum M, Goldsmith R, Bloomfield D, et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579-3586.
199. Baldwin KM, Joanisse DR, Haddad F, et al. Effects of weight loss and leptin on skeletal muscle in human subjects. Am J Physiol Regul Integr Comp Physiol 2011; 301: R1259-R1266.
200. Conroy R, Girotra M, Shane E, et al. Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism 2011; 60: 1222-1226.
201. Rosenbaum M, Sy M, Pavlovich K, et al. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest 2008; 118: 2583-2591.
202. Chong AY, Lupsa BC, Cochran EK, et al. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 2010; 53: 27-35.
203. Savage DB, O'Rahilly S. Leptin: a novel therapeutic role in lipodystrophy. J Clin Invest 2002; 109: 1285-1286.
204. Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901.
205. Lee CH, Reifsnyder PC, Naggert JK, et al. Novel leptin receptor mutation in NOD/LtJ mice suppresses type1 diabetes progression: I. Pathophysiological analysis. Diabetes 2005; 54: 2525-2532.
206. Lee CH, Chen YG, Chen J, et al. Novel leptin receptor mutation in NOD/LtJ mice suppresses type1 diabetes progression: II. Immunologic analysis. Diabetes 2006; 55: 171-178.
207. Matarese G, Sanna V, Lechler RI, et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002; 51: 1356-1361.